vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and MARCUS CORP (MCS). Click either name above to swap in a different company.

MARCUS CORP is the larger business by last-quarter revenue ($193.5M vs $134.9M, roughly 1.4× CareTrust REIT, Inc.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 2.8%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 18.2%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Marcus & Millichap, Inc. is an American company that provides real estate brokerage, mortgage brokerage, research, and advisory services in the U.S. and Canada in the field of commercial property. It popularized the practice of listing properties exclusively with one brokerage firm. The company has over 1,800 employees in more than 80 offices across the U.S. and Canada.

CTRE vs MCS — Head-to-Head

Bigger by revenue
MCS
MCS
1.4× larger
MCS
$193.5M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+52.4% gap
CTRE
55.1%
2.8%
MCS
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
18.2%
MCS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
MCS
MCS
Revenue
$134.9M
$193.5M
Net Profit
$111.3M
Gross Margin
Operating Margin
0.9%
Net Margin
82.5%
Revenue YoY
55.1%
2.8%
Net Profit YoY
113.5%
EPS (diluted)
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
MCS
MCS
Q4 25
$134.9M
$193.5M
Q3 25
$132.4M
$210.2M
Q2 25
$112.5M
$206.0M
Q1 25
$96.6M
$148.8M
Q4 24
$86.9M
$188.3M
Q3 24
$77.4M
$232.7M
Q2 24
$68.9M
$176.0M
Q1 24
$63.1M
$138.5M
Net Profit
CTRE
CTRE
MCS
MCS
Q4 25
$111.3M
Q3 25
$74.9M
$16.2M
Q2 25
$68.5M
$7.3M
Q1 25
$65.8M
$-16.8M
Q4 24
$52.1M
$986.0K
Q3 24
$33.4M
$23.3M
Q2 24
$10.8M
$-20.2M
Q1 24
$28.7M
$-11.9M
Operating Margin
CTRE
CTRE
MCS
MCS
Q4 25
0.9%
Q3 25
58.1%
10.8%
Q2 25
61.3%
6.3%
Q1 25
-13.7%
Q4 24
-1.2%
Q3 24
43.0%
14.1%
Q2 24
15.1%
1.3%
Q1 24
-12.0%
Net Margin
CTRE
CTRE
MCS
MCS
Q4 25
82.5%
Q3 25
56.6%
7.7%
Q2 25
60.9%
3.6%
Q1 25
68.1%
-11.3%
Q4 24
60.0%
0.5%
Q3 24
43.2%
10.0%
Q2 24
15.6%
-11.5%
Q1 24
45.6%
-8.6%
EPS (diluted)
CTRE
CTRE
MCS
MCS
Q4 25
$0.52
Q3 25
$0.35
Q2 25
$0.35
Q1 25
$0.35
Q4 24
$0.30
Q3 24
$0.21
Q2 24
$0.07
Q1 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
MCS
MCS
Cash + ST InvestmentsLiquidity on hand
$198.0M
$23.4M
Total DebtLower is stronger
$894.2M
$159.0M
Stockholders' EquityBook value
$4.0B
$457.4M
Total Assets
$5.1B
$1.0B
Debt / EquityLower = less leverage
0.22×
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
MCS
MCS
Q4 25
$198.0M
$23.4M
Q3 25
$712.5M
$7.4M
Q2 25
$306.1M
$14.9M
Q1 25
$26.5M
$11.9M
Q4 24
$213.8M
$40.8M
Q3 24
$377.1M
$28.4M
Q2 24
$495.1M
$32.8M
Q1 24
$451.2M
$17.3M
Total Debt
CTRE
CTRE
MCS
MCS
Q4 25
$894.2M
$159.0M
Q3 25
$893.8M
$162.0M
Q2 25
$1.2B
$179.9M
Q1 25
$822.1M
$198.9M
Q4 24
$396.9M
$159.1M
Q3 24
$396.7M
$173.1M
Q2 24
$671.1M
$175.7M
Q1 24
$595.9M
$169.8M
Stockholders' Equity
CTRE
CTRE
MCS
MCS
Q4 25
$4.0B
$457.4M
Q3 25
$4.0B
$454.3M
Q2 25
$3.3B
$448.4M
Q1 25
$2.9B
$441.8M
Q4 24
$2.9B
$464.9M
Q3 24
$2.4B
$462.3M
Q2 24
$1.9B
$449.4M
Q1 24
$1.7B
$459.3M
Total Assets
CTRE
CTRE
MCS
MCS
Q4 25
$5.1B
$1.0B
Q3 25
$5.1B
$1.0B
Q2 25
$4.7B
$1.0B
Q1 25
$3.9B
$1.0B
Q4 24
$3.4B
$1.0B
Q3 24
$2.9B
$1.0B
Q2 24
$2.7B
$1.1B
Q1 24
$2.3B
$1.0B
Debt / Equity
CTRE
CTRE
MCS
MCS
Q4 25
0.22×
0.35×
Q3 25
0.22×
0.36×
Q2 25
0.35×
0.40×
Q1 25
0.28×
0.45×
Q4 24
0.14×
0.34×
Q3 24
0.16×
0.37×
Q2 24
0.35×
0.39×
Q1 24
0.36×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
MCS
MCS
Operating Cash FlowLast quarter
$394.0M
$48.8M
Free Cash FlowOCF − Capex
$26.4M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
11.6%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$989.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
MCS
MCS
Q4 25
$394.0M
$48.8M
Q3 25
$100.9M
$39.1M
Q2 25
$100.8M
$31.6M
Q1 25
$71.4M
$-35.3M
Q4 24
$244.3M
$52.6M
Q3 24
$67.2M
$30.5M
Q2 24
$53.0M
$36.0M
Q1 24
$48.8M
$-15.1M
Free Cash Flow
CTRE
CTRE
MCS
MCS
Q4 25
$26.4M
Q3 25
$18.2M
Q2 25
$14.7M
Q1 25
$-58.3M
Q4 24
$27.1M
Q3 24
$12.0M
Q2 24
$16.1M
Q1 24
$-30.5M
FCF Margin
CTRE
CTRE
MCS
MCS
Q4 25
13.6%
Q3 25
8.7%
Q2 25
7.1%
Q1 25
-39.2%
Q4 24
14.4%
Q3 24
5.2%
Q2 24
9.2%
Q1 24
-22.0%
Capex Intensity
CTRE
CTRE
MCS
MCS
Q4 25
11.6%
Q3 25
9.9%
Q2 25
8.2%
Q1 25
15.5%
Q4 24
13.5%
Q3 24
7.9%
Q2 24
11.3%
Q1 24
11.1%
Cash Conversion
CTRE
CTRE
MCS
MCS
Q4 25
3.54×
Q3 25
1.35×
2.41×
Q2 25
1.47×
4.32×
Q1 25
1.08×
Q4 24
4.68×
53.31×
Q3 24
2.01×
1.31×
Q2 24
4.92×
Q1 24
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

MCS
MCS

Theatres$123.1M64%
Concessions$51.0M26%
Food And Beverage$21.2M11%

Related Comparisons